{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:13:02Z","timestamp":1790673182969,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.scr.2026.103975","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:23:29Z","timestamp":1774545809000},"page":"103975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["CRISPR\/Cas9 engineered and whole-genome characterized KIT D816V-mutant human iPSC lines"],"prefix":"10.1016","volume":"93","author":[{"given":"Yanyan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Fernandez","family":"Vallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Stachelscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Beule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9365-3785","authenticated-orcid":false,"given":"J\u00f6rg","family":"Scheffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.scr.2026.103975_b0005","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/all.15584","article-title":"KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes","volume":"78","author":"Navarro-Navarro","year":"2023","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.scr.2026.103975_b0010","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.25371","article-title":"Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management","volume":"94","author":"Pardanani","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.scr.2026.103975_b0015","unstructured":"Vallone, V.F., Ludwik, K., Healy, L., Lefort, N., Onder, T., Pavinato, L., et al, 2025. Good practices in hPSC handling. protocols.io. doi:10.1 7504\/protocols.io.j8nlk287wl5r\/v1."},{"key":"10.1016\/j.scr.2026.103975_b0020","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1002\/cpsc.123","article-title":"Methods for automated single cell isolation and sub-cloning of human pluripotent stem cells","volume":"55","author":"Vallone","year":"2020","journal-title":"Curr. Protoc. Stem Cell Biol."},{"issue":"3","key":"10.1016\/j.scr.2026.103975_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102406","article-title":"ASSURED-optimized CRISPR protocol for knockout\/SNP knockin in hiPSCs","volume":"4","author":"Ludwik","year":"2023","journal-title":"STAR Protoc."},{"issue":"10","key":"10.1016\/j.scr.2026.103975_b0030","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3390\/cancers14102487","article-title":"Comprehensive analysis of acquired genetic variants and their prognostic impact in systemic mastocytosis","volume":"14","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2022","journal-title":"Cancers"},{"issue":"Supplement 1","key":"10.1016\/j.scr.2026.103975_b0035","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1182\/blood-2023-184587","article-title":"Common pathways for acute myeloid leukemia progression in systemic mastocytosis with associated hematologic neoplasm","volume":"142","author":"Volpe","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.scr.2026.103975_b0040","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.18632\/oncotarget.14130","article-title":"Recurrent genetic defects on chromosome 5q in myeloid neoplasms","volume":"8","author":"Hosono","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.scr.2026.103975_b0045","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1038\/bcj.2014.94","article-title":"Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia","volume":"5","author":"Lasho","year":"2015","journal-title":"Blood Cancer J."},{"issue":"8","key":"10.1016\/j.scr.2026.103975_b0050","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ajh.26966","article-title":"The international consensus classification of eosinophilic disorders and systemic mastocytosis","volume":"98","author":"Wang","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.scr.2026.103975_b0055","doi-asserted-by":"crossref","unstructured":"D'Ambrosio, C., Akin, C., Wu, Y., Magnusson, M.K., Metcalfe, D.D., 2003. Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers. 112(6), 1162\u20131117.","DOI":"10.1016\/j.jaci.2003.07.008"},{"key":"10.1016\/j.scr.2026.103975_b0060","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/leu.2009.85","article-title":"Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms","volume":"23","author":"Wang","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.scr.2026.103975_b0065","doi-asserted-by":"crossref","first-page":"2S55","DOI":"10.1016\/j.clml.2015.07.113","article-title":"Genomic landscape in KIT D816V+ advanced systemic mastocytosis","volume":"15","author":"Jawhar","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.scr.2026.103975_b0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jmoldx.2018.07.002","article-title":"Clinical significance of DNA variants in chronic myeloid neoplasms: a report of the association for molecular pathology","volume":"20","author":"McClure","year":"2018","journal-title":"J. Mol. Diagn."},{"issue":"8","key":"10.1016\/j.scr.2026.103975_b0075","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.5858\/arpa.2021-0124-OA","article-title":"Designing myeloid gene panels","volume":"146","author":"Zhao","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.scr.2026.103975_b0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/asheducation-2011.1.250","article-title":"World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants","volume":"2011","author":"Vardiman","year":"2011","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.scr.2026.103975_b0085","first-page":"e10","article-title":"The role of JAK2 abnormalities in hematologic neoplasms","volume":"1","author":"Alabdulaali","year":"2009","journal-title":"Hematol. Rev."},{"issue":"1","key":"10.1016\/j.scr.2026.103975_b0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2015.284","article-title":"Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.scr.2026.103975_b0095","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1097\/HS9.0000000000000478","article-title":"Discordant response of systemic mastocytosis associated with myelodysplastic syndrome after midostaurin and allogeneic hematopoietic stem-cell transplantation","volume":"4","author":"Haas","year":"2020","journal-title":"Hemasphere"},{"issue":"5","key":"10.1016\/j.scr.2026.103975_b0100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.2018886507","article-title":"Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis","volume":"134","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2019","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.scr.2026.103975_b0105","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/bloodadvances.2018020628","article-title":"Impact of somatic and germline mutations on the outcome of systemic mastocytosis","volume":"2","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.scr.2026.103975_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2024.103377","article-title":"Generation of two human induced pluripotent stem cell lines with BAX and BAK1 double knock-out using CRISPR\/Cas9","volume":"76","author":"Ludwik","year":"2024","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.scr.2026.103975_b0115","article-title":"Chromosome preparation from cultured cells","volume":"83","author":"Howe","year":"2014","journal-title":"J. Vis. Exp."}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506126000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506126000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:12:12Z","timestamp":1782461532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506126000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":23,"alternative-id":["S1873506126000711"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2026.103975","relation":{},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR\/Cas9 engineered and whole-genome characterized KIT D816V-mutant human iPSC lines","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2026.103975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103975"}}